Erick McNair
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Natural Antidiabetic Agents Studies
Papers in
-
- Renal Transplantation Outcomes and Treatments 4
-
- Advanced Glycation End Products research 6
- Co-authors
- Kailash PrasadColin PearceC. Robert E. WellsMabood QureshiJill BallyShelley SpurrAdnan I. QureshiDorothy Thomson
- Journals
- Molecular and Cellular Biochemistry (3 papers)Perfusion (3 papers)Journal of ExtraCorporeal Technology (2 papers)Scientific Reports (1 paper)Circulation Heart Failure (1 paper)
- Partner nations
- CanadaUnited StatesPoland
In The Last Decade
Erick McNair
24 papers receiving 331 citations
Peers
Comparison fields: 5 of 84
- Clinical Biochemistry 134
- Endocrinology, Diabetes and Metabolism 101
- Biochemistry 21
- Cardiology and Cardiovascular Medicine 74
- Internal Medicine 12
Countries citing papers authored by Erick McNair
This map shows the geographic impact of Erick McNair's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erick McNair with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erick McNair more than expected).
Fields of papers citing papers by Erick McNair
This network shows the impact of papers produced by Erick McNair. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erick McNair. The network helps show where Erick McNair may publish in the future.
Co-authors
The 25 scholars most cited alongside Erick McNair, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 0 | |
| 4 | 2022 | 13 | |
| 5 | 2021 | 6 | |
| 6 | 2021 | 0 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 20 | |
| 10 | 2018 | 7 | |
| 11 | 2018 | 4 | |
| 12 | 2015 | 4 | |
| 13 | 2014 | 3 | |
| 14 | 2013 | 5 | |
| 15 | 2012 | 21 | |
| 16 | 2011 | 11 | |
| 17 | 2010 | 40 | |
| 18 | 2010 | 21 | |
| 19 | 2009 | 45 | |
| 20 | 2009 | 8 |
About Erick McNair
Erick McNair is a scholar working on Transplantation, Clinical Biochemistry, Biochemistry, Internal Medicine and Cardiology and Cardiovascular Medicine, having authored 27 papers that have together received 336 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (6 papers), Renal Transplantation Outcomes and Treatments (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers), Organ Transplantation Techniques and Outcomes (4 papers), Blood transfusion and management (3 papers), Transplantation: Methods and Outcomes (3 papers), Cardiac and Coronary Surgery Techniques (3 papers) and Acute Myocardial Infarction Research (3 papers). The work is most often cited by research in Clinical Biochemistry (134 citations), Endocrinology, Diabetes and Metabolism (101 citations), Biochemistry (21 citations), Cardiology and Cardiovascular Medicine (74 citations) and Internal Medicine (12 citations). Erick McNair has collaborated with scholars based in Canada, United States and Poland. Frequent co-authors include Kailash Prasad, Colin Pearce, C. Robert E. Wells, Mabood Qureshi, Jill Bally, Shelley Spurr, Adnan I. Qureshi, Dorothy Thomson, Diane Allan and John F. Gamble. Their work appears in journals such as Molecular and Cellular Biochemistry, Perfusion, Journal of ExtraCorporeal Technology, Scientific Reports and Circulation Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.